S19-413 Potential Disease-Modifying Drug Combination for Osteoarthritis Researchers at Stanford have discovered that treatment with JNK II inhibitor and IBMX has a synergistic therapeutic effect against osteoarthritis (OA). Nidhi Bhutani Fiorella Grandi